MedPage Today on MSN
New acute PE classification; cardiac xenografting consensus; novel VTE biomarkers
Recent developments of interest in cardiovascular medicine ...
Morning Overview on MSN
Scientists find hidden trigger killing inner ear cells and a new way to stop hearing loss
Researchers have identified a previously unknown mechanism that drives the death of inner ear hair cells, the tiny sensory structures responsible for converting sound into brain signals. The discovery ...
Ethanol is widely used in industrial processing, food production, medical diagnostics, and transportation, but its volatility and potential health risks demand reliable monitoring at low ...
Affinia Therapeutics ("Affinia"), an innovative gene therapy company with a pipeline of first-in-class and/or best-in-class adeno-associated virus (AAV) gene therapies initially for devastating ...
Professor Zhen Zhang's research group at the State Key Laboratory of Bionic Interface Materials Science, University of ...
Retina-inspired cascaded van der Waals heterostructures for photoelectric-ion neuromorphic computing
Professor Zhen Zhang's research group at the State Key Laboratory of Bionic Interface Materials Science, University of Science and Technology of China, proposed and constructed a neuromorphic ...
That’s gene editing. On paper, it is merely the rearrangement of letters. However, the road to editing genes in hopes of a therapeutic benefit is difficult to travel. Additionally, researchers want ...
You are free to share (copy and redistribute) this article in any medium or format within the parameters below: Creative Commons (CC): This is a Creative Commons license. Attribution (BY): Credit must ...
SAN JOSE, Calif.--(BUSINESS WIRE)-- Takara Bio USA, Inc., a wholly owned subsidiary of Takara Bio Inc., today announced the launch of the Lenti-X™ Transduction Sponge, a first-to-market dissolvable ...
BOSTON--(BUSINESS WIRE)--Kelonia Therapeutics, a biotech company revolutionizing in vivo gene delivery, today announced new preclinical data from its lead program KLN-1010, which will be presented at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results